Viewing Study NCT05947669


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-28 @ 8:30 AM
Study NCT ID: NCT05947669
Status: RECRUITING
Last Update Posted: 2023-08-24
First Post: 2023-06-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Sponsor: Odense University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module